An Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
An Xiao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Jianhui Fan
Radiology Department, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology
1 shared publication- Jiawei Geng
Department of Infectious Disease and Hepatic Disease, the First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming 650100, China
1 shared publication - Jiawei Geng
Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
1 shared publication Lili Zuo
Department of Infectious Diseases and Hepatic Diseases, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology
1 shared publicationLing Zhu
Kunming Univ Sci & Technol, Affiliated Hosp, Peoples Hosp Yunnan Prov 1, Dept Infect Dis & Hepat Dis, Kunming 650032, Yunnan, Peoples R China
1 shared publicationLu Qian
Department of Pathology, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752125
Multiple pulmonary cavities as the prominent manifestation of diffuse large B-cell lymphoma: a case report
A 60-year-old man complaining of fever, lacking in strength and with poor appetite for half month, was admitted to our Department of Infectious Diseases and Hepatic Diseases. The patient’s chest computed tomography revealed multiple cavities in the lungs. And he was diagnosed with diffuse large B‐cell lymphoma following the positron emission tomography–computed tomography scan and laparoscopic lymph node biopsy. His symptoms and the pulmonary cavity lesions improved significant after eight cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752125
Open AccessMultiple pulmonary cavities as the prominent manifestation of diffuse large B-cell lymphoma: a case report
A 60-year-old man complaining of fever, lacking in strength and with poor appetite for half month, was admitted to our Department of Infectious Diseases and Hepatic Diseases. The patient’s chest computed tomography revealed multiple cavities in the lungs. And he was diagnosed with diffuse large B‐cell lymphoma following the positron emission tomography–computed tomography scan and laparoscopic lymph node biopsy. His symptoms and the pulmonary cavity lesions improved significant after eight cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
- Open Access
- 1 January 2022
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 36 (3) , 215-6
Drug-induced severe liver injury due to Sterculia versicolor: a case report with causality assessment from possible to probable
Sterculia gum, the dry exudate of Sterculia versicolor and other members of the same genus, is used as a thickener and emulsifier in foods. It is generally considered safe as a food or drug, and its adverse reactions, such as Sterculia-induced liver injury, have never been reported. A 46-year-old woman was admitted to hospital with fatigue, nausea, abdominal distension, jaundice and a >16-fold increase in transaminase and bilirubin level. The patient had used Sterculia gum prior to the onset of her symptoms. Her symptoms and clinical indicators improved after treatment. The possibility of acute viral hepatitis, autoimmune hepatitis, and metabolic liver disease was excluded. After discharge from hospital, the patient had a severe liver injury again when re-exposed to Sterculia gum. And the Roussel Uclaf Causality Assessment Method score was updated from 5 to 7, which was consistent with probable drug-induced liver injury. This is the first report of Sterculia-induced liver injury. Clinicians need to be aware of the potential hepatotoxicity of Sterculia.
- 1 January 2022
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 36 (3) , 215-6
Open AccessDrug-induced severe liver injury due to Sterculia versicolor: a case report with causality assessment from possible to probable
Sterculia gum, the dry exudate of Sterculia versicolor and other members of the same genus, is used as a thickener and emulsifier in foods. It is generally considered safe as a food or drug, and its adverse reactions, such as Sterculia-induced liver injury, have never been reported. A 46-year-old woman was admitted to hospital with fatigue, nausea, abdominal distension, jaundice and a >16-fold increase in transaminase and bilirubin level. The patient had used Sterculia gum prior to the onset of her symptoms. Her symptoms and clinical indicators improved after treatment. The possibility of acute viral hepatitis, autoimmune hepatitis, and metabolic liver disease was excluded. After discharge from hospital, the patient had a severe liver injury again when re-exposed to Sterculia gum. And the Roussel Uclaf Causality Assessment Method score was updated from 5 to 7, which was consistent with probable drug-induced liver injury. This is the first report of Sterculia-induced liver injury. Clinicians need to be aware of the potential hepatotoxicity of Sterculia.